Metabolic and hormonal alterations in cats with hepatic lipidosis.
Hepatic lipidosis in cats is a commonly diagnosed hepatobiliary disease of unknown cause. The purpose of this prospective study was to characterize the blood hormone and lipid status of cats with hepatic lipidosis, and to compare this status to that of cats with other types of liver disease and to control cats. Twenty-three cats with hepatic disease were assigned to 1 of 2 groups on the basis of cytopathologic or histopathologic examination of the liver: group 1, hepatic lipidosis (n = 18); or group 2, cholangiohepatitis (n = 5). Ten healthy young adult cats were used as controls. Food was withheld from control animals for 24 hours before blood collection. Concentrations of plasma glucagon and serum insulin, cortisol, thyroxine, triglycerides, cholesterol, phospholipids, and nonesterified fatty acids (NEFAs) were determined in all cats, in addition to routine hematologic and serum biochemical testing. Cats with hepatic lipidosis had higher serum NEFA concentrations than cats with cholangiohepatitis or control cats (P < .05). Cats with cholangiohepatitis had higher serum cholesterol and phospholipid concentrations than those of cats with lipidosis or control cats (P < .05); their plasma glucagon concentrations were higher than those of control cats (P < .05), but were not different from those of cats with hepatic lipidosis. Serum insulin concentrations were significantly higher in control cats than in diseased cats (P < .05), but neither serum insulin nor the insulin to glucagon ratio was significantly different among the cats with hepatic disease. The high concentration of NEFAs in cats with hepatic lipidosis suggests that at least 1 factor in the pathogenesis of this syndrome may involve the regulation of hormone-sensitive lipase.
Brown
B
B
Department of Medicine, The Elmer and Mamdouha Bobst Hospital of The Animal Medical Center, New York, NY, USA.
Mauldin
G E
GE
Armstrong
J
J
Moroff
S D
SD
Mauldin
G N
GN
D000818:Animals; D000855:Anorexia / Q000209:etiology / Q000662:veterinary; D002371:Cat Diseases / Q000175:diagnosis / Q000473:pathology*; D002415:Cats; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005934:Glucagon / Q000378:metabolism; D007328:Insulin / Q000097:blood; D008064:Lipidoses / Q000175:diagnosis / Q000473:pathology / Q000662:veterinary*; D008055:Lipids / Q000097:blood*; D008107:Liver Diseases / Q000175:diagnosis / Q000473:pathology / Q000662:veterinary*; D011446:Prospective Studies; D012016:Reference Values
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D008055:Lipids; D005934:Glucagon